Delivery Order SPE2DB22D2206-SPE2DB25FKD94
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This firm fixed-price delivery order, valued at $25,119.14, was competitively awarded without set-aside designation and is scheduled for completion by September 9, 2025. The product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical settings. This firm fixed-price delivery order, valued at $1,546.78, was competitively awarded without set-aside designations and is scheduled for completion by August 7, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical procedures. This firm fixed-price delivery order, valued at $4,839.49, represents a competitive award with no set-aside designation and is scheduled for completion by August 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $16,136.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a topical thrombin product used in surgical hemostasis. Issued on August 22, 2025, with an ultimate completion date of August 25, 2025, this non-set-aside contract represents a child delivery order under AmerisourceBergen's larger prime indefinite delivery contract (IDC SPE2DX) valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 5,000 unit vials of Recothrom, a pharmaceutical product used in surgical hemostasis. This firm fixed-price delivery order, valued at $2,567.33, was competitively awarded without set-aside designation and is scheduled for completion by August 13, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $7,476.11 delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical and wound care applications. This competitively awarded, firm fixed-price delivery order was issued on September 17, 2025, with an ultimate completion date of September 18, 2025, and represents a non-set-aside procurement. The contract will be performed at AmerisourceBergen's corporate office location in...
- This delivery order, awarded May 12, 2025, obligates $8,481.60 to AmerisourceBergen Drug Corp for the supply of 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. The award is non-competitive and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. Performance will be completed by May 13, 2025, at the...
- This delivery order, valued at $4,087.14, was awarded on September 24, 2025, to AmerisourceBergen Drug Corp for the supply of 20,000 unit vials of Recothrom. The contract was funded by the Defense Logistics Agency (DLA), a Department of Defense organization responsible for supplying medical and other commodities to military and federal healthcare systems. The award utilized firm fixed-price pricing with no set-aside designation, indicating the contract was competitively awarded. Performance will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of RECOTHROM under a firm fixed-price contract with a ceiling value of $1,696.32. The order, which was not set-aside designated and competitively awarded, was executed on June 25, 2025, with an ultimate completion date of June 26, 2025. Performance will take place at the vendor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $3,582.76 delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of RECOTHROM under a firm fixed price contract, with an ultimate completion date of July 21, 2025. This is a non-set-aside award issued on July 18, 2025, with performance to be completed in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKD94Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications, with a ceiling value of $17,401.91. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 30, 2025. The award was issued on September 29, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen utilizes this comprehensive global pharmaceutical support vehicle to supply a wide range of medications, vaccines, medical devices, and specialized healthcare commodities to military healthcare systems and other federal customers worldwide. The company's consistent track record of competitively awarded, non-set-aside contracts demonstrates its capability to fulfill federal procurement requirements across multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.4k | 9/29/25 |